abstract |
The present invention relates to novel peptide compounds, more particularly to micro-peptides derived from lncRNA associated with cancer and cellular plasticity. It also relates to the use of said mini-peptides in the treatment of proliferative diseases, more particularly in the treatment of cancer. |